The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.226%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 15.75
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EARNINGS SUMMARY: Novacyt Profit Leaps On Covid-19 Test Kit Demand

Thu, 17th Sep 2020 15:39

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Novacyt SA - Surrey-based biotechnology company making Covid-19 test kits - Revenue for six months to June 30 rockets to EUR72.4 million from EUR7.2 million, with Primerdesign revenue multiplying to EUR70.6 million from EUR3.3 million due to the success of the Covid-19 product portfolio. Margins increase to 83% from 63%. Swings to pretax profit of EUR46.1 million from a EUR1.2 million loss due to revenue surge. First half earnings before interest, tax, depreciation and amortisation surge to EUR49.4 million from EUR153,000. Revenue for the second half to be greater than the first half of the year and margins to be at least at a similar level. Full year revenue expected to exceed EUR150 million and Ebitda to exceed EUR100 million. Cash at June 30 of EUR19.7 million after paying down all long-term debt and significant working capital investment made into stock to ensure the continuity of supply to meet the demand for Covid-19 tests. Shares up 5.0% at 388.50 pence.

----------

ThinkSmart Ltd - Australian digital payments platform business - Pretax profit for year ended June 30 multiplies to GBP53.1 million from GBP524,000, driven by GBP53.7 million fair value gain on revaluation of the retained shareholding in Clearpay Finance Ltd. Revenue falls year-on-year to GBP6.1 million from GBP7.2 million. Continues to manage the wind down of legacy business. Cash and cash equivalents of GBP8.8 million at June 30. Shares up 17% at 44.00 pence.

----------

Supermarket Income REIT PLC - UK-focused supermarket income trust - To raise GBP150 million by way of a placing and subscription of shares at 104 pence each, a 6.3% discount to Wednesday's closing stock price of 111p. Current stock price 109.00p, down 1.8%. Proceeds to fund investment opportunities which are currently in excess of GBP400 million. EPRA net asset value per share for the 12 months to June 30 rises 4% to 101p. Passing rent up 49% at GBP28.7 million. 100% of all rents collected in full. Annual dividend up 3.8% at 5.8p. Increases dividend target for financial 2021 to 5.86p.

----------

Aberdeen Smaller Companies Income Trust PLC - investment trust focused on smaller UK companies - Net asset value total return for six months to June 30 minus 16.9% versus minus 25.0% return from Numis Small Companies excluding Investment Trust index. Net asset value per share 306.14p at June 30, down 18% from 373.86p at December 31. Attributes negative return to Covid-19 pandemic. Stock down 0.8% at 262.00 pence.

----------

DX Group PLC - Slough-based courier and logistics services - Revenue for year ended June 27 rises 2.1% to GBP329.3 million from GBP322.5 million. Pretax loss narrows to GBP1.3 million from GBP1.7 million. Revenue fell by a third immediately post-lockdown, but volumes steadily recovered from April and are now above levels anticipated pre-lockdown. Trading in the first months of financial 2020 ahead of the same period last year. Healthy pipeline of new business opportunities. Sees opportunity to increase volumes and further expand margins. Net cash of GBP12.3 million at June 27, better than expected. Shares down 11% at 17.15 pence.

----------

Destiny Pharma PLC - Brighton-based biotechnology company - Pretax loss for the six months to June 30 widens year-on-year to GBP2.9 million from GBP2.4 million. No revenue generated as the company is still in clinical stage of developing products. Research and development costs rise to GBP2.3 million from GBP1.7 million. Funded through fourth-quarter of 2021. Strong cash position with cash and term deposits of GBP5.6 million at June 30. Stock up 3.5% at 60.00 pence.

----------

GCP Student Living PLC - UK-focused student accommodation provider - EPRA net asset value per share for year to June 30 171.78 pence, up from 165.52p a year ago. Property portfolio value rises to GBP1.00 billion from GBP921.6 million. Student rental growth 4.4% versus 3.5%. Rental income rises year-on-year to GBP47.8 million from GBP44.4 million. Chair Robert Peto to retire at 2020 annual general meeting. Annual dividend unchanged at 6.15p. Shares up 2.2% at 139.00p.

----------

Enwell Energy PLC - Ukraine-focused oil and gas explorer - Revenue for six months to June 30 falls 21% year-on-year to USD24.7 million as a result of weakened gas prices in the period. Pretax profit falls 80% to USD2.6 million from USD13.3 million. Average daily production from the MEX-GOL, SV and VAS fields of 4,545 barrels of oil equivalent per day, down 8% from 4,192 barrels. Cash and cash equivalents of USD54.2 million at June 30 and USD55.5 million at September 13. Shares down 2.5% at 15.13 pence.

----------

Gresham House PLC - London-based asset manager - Assets under management rises 17% in the six months to June 30 to GBP3.26 billion from GBP2.80 billion at December 31, helped by 10% organic growth. Core income up 33% to GBP17.8 million. Pretax loss widens year-on-year to GBP1.6 million from GBP801,000. Well placed for the second half of 2020 and beyond. Strong balance sheet with cash and liquid assets at GBP45.1 million and zero debt. Shares up 5.0% at 724.80 pence.

----------

Regional REIT Ltd - UK-focused real estate investment trust - EPRA net asset value per share falls to 102.6 pence at June 30 from 112.7p at December 31. Resilient rental and property income in six months to June-end of GBP29.4 million versus GBP29.9 million. Rent collection strong with 97.6% of the rent invoiced for the period to June 30 being collected as at September 11. EPRA occupancy rate stable at 89.0%. Cuts first half dividend to 3.4p from 3.8p. Targeting an expected full year dividend of 6.4p. Cash and cash equivalent GBP67.9 million. Shares up 2.8% at 68.89p.

----------

Zephyr Energy PLC - technology-led oil and gas exploration company focused on US - Swings to a pretax profit of USD906,000 for the six months to June 30 from USD826,000 loss due to foreign exchange gains of USD1.6 million versus USD126,000 loss. No revenue generated in either financial periods. Administrative costs fall year-on-year to USD613,000 from USD806,000. Shares down 2.6% at 0.76 pence.

----------

Wilmington PLC - London-based data and information services company - Results for 12 months to June 30 at the top end of range previously provided for both revenue and profit. Revenue for the year down 8% to GBP113.1 million, hurt by no face-to-face events or training in final quarter. Pretax profit down 56% at GBP6.4 million due to Covid-19 impact and absence of disposal gains. Net debt improves to GBP27.7 million at June 30 from GBP33.9 million a year ago. Dividend suspended but remains committed to a resumption of dividends as soon as the trading environment normalises. Profitable in the first two months of financial 2021. Shares down 0.4% at 130.00 pence.

----------

Velocys PLC - Oxford, England-based fuels technology company - Revenue multiplies to GBP180,000 for six months ended June 30 from GBP22,000 a year ago. Pretax loss narrows to GBP2.7 million from GBP4.7 million. Sees significant uplift in demand for sustainable fuels. Cash at period end of GBP816,000 versus GBP4.8 million at December 31. Shares up 2.8% at 6.80p.

----------

SolGold PLC - Australian gold and copper mining company - Pretax loss for the year to June 30 narrows year-on-year to USD13.0 million from USD32.7 million due to a sharp drop in share based payment expenses to USD1.2 million from USD23.9 million. No revenue generated in either financial period. Administrative expenses rise to USD12.4 million from USD9.2 million. Shares down 1.5% at 26.99 pence.

----------

DP Aircraft I Ltd - Guernsey-based aircraft leasing company - Net asset value per share plummets to USD0.6502 for the six months to June 30 from USD1.0304 at December 31. Lease rental income for the first half falls to USD24.4 million from USD28.6 million. Swings to pretax loss of USD72 million from USD11.7 million. Books USD71.2 million impairment against aircraft assets and USD15.7 million against the lease premium, in light of Covid-19 pandemic. Prioritising the preservation of long-term financial stability. Available cash projected at the end of September of USD3 million. Stock up 0.1% at USD0.090.

----------

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
20 May 2022 16:00

UK shareholder meetings calendar - next 7 days

Monday 23 May 
Brewin Dolphin Holdings PLCGM re acquisition by RBC Wealth Management
Digital 9 Infrastructure PLCAGM
Empiric Student Property PLCAGM
TMT Investments PLCAGM
Tuesday 24 May 
4imprint Group PLCAGM
Afentra PLCAGM
Artisanal Spirits Co PLCAGM
Bidstack Group PLCAGM
Epwin Group PLCAGM
FDM Group Holdings PLCAGM
Forterra PLCAGM
Harworth Group PLCAGM
Henderson High Income Trust PLCAGM
Hill & Smith Holdings PLCAGM
Hilton Food Group PLCAGM
Horizonte Minerals PLCAGM
Judges Scientific PLCAGM
Pebble Group PLCAGM
Quarto Group IncAGM
Restaurant Group PLCAGM
Riverstone Energy LtdAGM
Shell PLCAGM
Thungela Resources LtdAGM
Vector Capital PLCAGM
WPP PLCAGM
Wednesday 25 May  
Access Intelligence PLCAGM
Amur Minerals CorpAGM
Aston Martin Lagonda Global Holdings PLCAGM
Bakkavor Group PLCAGM
Bango PLCAGM
Bodycote PLCAGM
Eleco PLCAGM
International Public Partnerships LtdAGM
Intertek Group PLCAGM
M&G PLCAGM
Manx Financial Group PLCAGM
Mortgage Advice Bureau Holdings PLCAGM
Property Franchise Group PLCGM re final 2021 dividend
Regional REIT LtdAGM
Sabre Insurance Group PLCAGM
Trustpilot Group PLCAGM
Tullow Oil PLCAGM
Zenova Group PLCAGM
Zotefoams PLCAGM
Thursday 26 May 
Aminex PLCAGM
Bank of Ireland Group PLCAGM
Belvoir Group PLCAGM
Central Asia Metals PLCAGM
Curtis Banks Group PLCAGM
Diaceutics PLCAGM
Duke Royalty LtdEGM re fundraise
East Star Resources PLCAGM
Energean PLCAGM
Henry Boot PLCAGM
Hochschild Mining PLCAGM
Legal & General Group PLCAGM
National World PLCAGM
Ocean Wilsons Holdings LtdAGM
OnTheMarket PLCGM re cancellation of capital
Prudential PLCAGM
S&U PLCAGM
Staffline Group PLCAGM
Strix Group PLCAGM
WAG Payment Solutions PLCAGM
Yu Group PLCAGM
Friday 27 May 
AG Barr PLCAGM
Big Technologies PLCAGM
Coca-Cola Europacific Partners PLCAGM
Destiny Pharma PLCAGM
Hostmore PLCAGM
Lancashire Holdings LtdAGM
Lekoil LtdEGM re appointment and remuneration of auditors
LSL Property Services PLCAGM
Malin Corp PLCAGM
Old Mutual LtdAGM
Oxford BioMedica PLCAGM
Renewables Infrastructure Group LtdAGM
Spectris PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
12 May 2022 19:45

TRADING UPDATES: Belluscura to raise GBP5 million; React buys

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
3 May 2022 21:55

TRADING UPDATES: Vela, Standard Life Investments up portfolio value

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
3 May 2022 12:16

Destiny Pharma appoints Yuri Martina as chief medical officer

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the appointment of Dr Yuri Martina as its chief medical officer on Tuesday.

Read more
12 Apr 2022 12:42

EARNINGS UPDATES: Parsley Box widens loss; M Winkworth profit doubles

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Apr 2022 16:34

UK earnings, trading statements calendar - next 7 days

Wednesday 6 April  
Applied Graphene Materials PLCHalf Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Hilton Food Group PLCFull Year Results
Hyve Group PLCTrading Statement
Topps Tiles PLCTrading Statement
Wentworth Resources PLCFull Year Results
Thursday 7 April 
Alpha Financial Markets Consulting PLCTrading Statement
Attraqt Group PLCFull Year Results
Entain PLCQ1 Results
Robert Walters PLCQ1 Results
Tracsis PLCHalf Year Results
Friday 8 April 
CMC Markets PLCTrading Statement
Ferrexpo PLCTrading Statement
Monday 11 April 
Tortilla Mexican Grill PLCFull Year Results
Sirius Real Estate LtdTrading Statement
Tuesday 12 April 
ASOS PLCHalf Year Results
Cambridge Cognition Holdings PLCFull Year Results
Destiny Pharma PLCFull Year Results
easyJet PLCTrading Statement
Filta Group Holdings PLCFull Year Results
JD Sports Fashion PLCFull Year Results
Liontrust Asset ManagementTrading Statement
M Winkworth PLCFull Year Results
Moneysupermarket.com Group PLCTrading Statement
Nanoco Group PLCHalf Year Results
Pennon Group PLCTrading Statement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
25 Mar 2022 14:26

IN BRIEF: Destiny Pharma raises GBP450,000 through open offer

Destiny Pharma PLC - a clinical-stage biotechnology company based in Brighton, England - Raises total gross proceeds of GBP450,000 through its open offer. Has conditionally raised total gross proceeds of GBP6.5 million through its placing, subscription, and open offer. Says it has applied for the admission of 12.9 million shares, consisting of 11.9 million placing shares, 140,000 subscription shares and 909,007 open offer shares.

Read more
8 Mar 2022 19:38

IN BRIEF: Destiny Pharma to raise GBP7.0 million for asset trials

Destiny Pharma PLC - clinical-stage biotechnology company based in Brighton, England - Intends to raise GBP7.0 million through a placing of 11.9 million shares at 50 pence each, subscription for 140,000 shares and an open offer for 2.0 million shares.

Read more
8 Mar 2022 13:55

Destiny Pharma to raise up to £7m in discounted fundraising

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma said on Tuesday that it was looking to raise up to £7m in a conditional fundraising to continue progress towards Phase 3 in its two lead clinical assets.

Read more
8 Feb 2022 20:36

IN BRIEF: Destiny Pharma receives Europe watchdog XF-73 boost

IN BRIEF: Destiny Pharma receives Europe watchdog XF-73 boost

Read more
8 Feb 2022 15:07

Destiny upbeat on nasal gel feedback from EMA

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said on Tuesday that it has received positive scientific advice from the European Medicines Agency (EMA), following its review of its proposed phase 3 clinical programme design.

Read more
1 Feb 2022 14:57

Destiny successfully completes preclinical study of dermal formulation

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the successful completion of a preclinical safety study with a novel 'XF-73' dermal formulation on Tuesday.

Read more
24 Jan 2022 13:44

Destiny Pharma reports success in US C. diff trial

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the successful outcome of its cooperative research and development agreement with the US Department of Veterans Affairs (VA) on Monday.

Read more
21 Jan 2022 14:36

IN BRIEF: Destiny Pharma notes study that shows need for XF platform

IN BRIEF: Destiny Pharma notes study that shows need for XF platform

Read more
17 Jan 2022 18:40

TRADING UPDATES: MP Evans declares special payout as production rises

TRADING UPDATES: MP Evans declares special payout as production rises

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.